| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value
|
Li, Jing
|
|
|
100 |
12 |
p. 2979-2988
|
artikel
|
| 2 |
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study
|
Wang, Xiao-Xiao
|
|
|
100 |
12 |
p. 2961-2968
|
artikel
|
| 3 |
Caplacizumab: frequent local skin reactions
|
Kaufeld, Jessica
|
|
|
100 |
12 |
p. 3051-3052
|
artikel
|
| 4 |
Circulating blastoid cells: acute leukemia, prolymphocytic leukemia, or something else?
|
Zhao, Yue
|
|
|
100 |
12 |
p. 3047-3048
|
artikel
|
| 5 |
Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide
|
El-Khazragy, Nashwa
|
|
|
100 |
12 |
p. 2909-2917
|
artikel
|
| 6 |
Clonal IgH gene rearrangements identify Richter’s transformation to diffuse large B cell lymphoma
|
Dalela, Disha
|
|
|
100 |
12 |
p. 3075-3077
|
artikel
|
| 7 |
Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma
|
Takeoka, Kayo
|
|
|
100 |
12 |
p. 3043-3045
|
artikel
|
| 8 |
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
|
Villacampa, Guillermo
|
|
|
100 |
12 |
p. 2969-2978
|
artikel
|
| 9 |
Correction to: Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide
|
El-Khazragy, Nashwa
|
|
|
100 |
12 |
p. 2919
|
artikel
|
| 10 |
Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
|
Kang, Ka-Won
|
|
|
100 |
12 |
p. 3083
|
artikel
|
| 11 |
Cutaneous botryomycosis mimicking ecthyma gangrenosum in a patient treated with ibrutinib
|
Pulido-Pérez, Ana
|
|
|
100 |
12 |
p. 3065-3066
|
artikel
|
| 12 |
Cutaneous marginal zone lymphoma following anthrax vaccination
|
Chandler, Jocelyn B.
|
|
|
100 |
12 |
p. 3079-3080
|
artikel
|
| 13 |
Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group
|
Kimura, Shun-ichi
|
|
|
100 |
12 |
p. 3029-3038
|
artikel
|
| 14 |
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells
|
Baumeister, Julian
|
|
|
100 |
12 |
p. 2943-2956
|
artikel
|
| 15 |
EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis
|
Wong, Ian Y.
|
|
|
100 |
12 |
p. 3061-3063
|
artikel
|
| 16 |
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
|
Isola, Ignacio
|
|
|
100 |
12 |
p. 2997-3005
|
artikel
|
| 17 |
Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent β-thalassemia: a comprehensive single-center experience
|
Karimi, Mehran
|
|
|
100 |
12 |
p. 2901-2907
|
artikel
|
| 18 |
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry
|
Sato, Kota
|
|
|
100 |
12 |
p. 2989-2995
|
artikel
|
| 19 |
Phase II study of single-agent nivolumab in patients with myelofibrosis
|
Abou Dalle, Iman
|
|
|
100 |
12 |
p. 2957-2960
|
artikel
|
| 20 |
Plasma cell myeloma with pure lymphocyte-like morphology
|
Lee, Kyoungyul
|
|
|
100 |
12 |
p. 3071-3073
|
artikel
|
| 21 |
Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation—a single-center analysis
|
Karakulska-Prystupiuk, Ewa
|
|
|
100 |
12 |
p. 3007-3016
|
artikel
|
| 22 |
Questioning the association between ABO type and outcomes in patients with COVID-19
|
May, Jori E.
|
|
|
100 |
12 |
p. 3081-3082
|
artikel
|
| 23 |
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma
|
Mouhieddine, Tarek H.
|
|
|
100 |
12 |
p. 3057-3060
|
artikel
|
| 24 |
Stem cell transplantation for hemoglobinopathy Vila Real
|
Hasenkamp, Justin
|
|
|
100 |
12 |
p. 3041-3042
|
artikel
|
| 25 |
Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation
|
Miura, Yoko
|
|
|
100 |
12 |
p. 3067-3069
|
artikel
|
| 26 |
Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy
|
Tang, Wenjiao
|
|
|
100 |
12 |
p. 3039-3040
|
artikel
|
| 27 |
Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma
|
Moore, Donald C.
|
|
|
100 |
12 |
p. 3053-3055
|
artikel
|
| 28 |
Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trials
|
Cohen, Inbar
|
|
|
100 |
12 |
p. 2879-2887
|
artikel
|
| 29 |
Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma
|
Yip, Pui-Lun
|
|
|
100 |
12 |
p. 3049-3050
|
artikel
|
| 30 |
The anemia-independent impact of myelodysplastic syndromes on health-related quality of life
|
Wouters, Hanneke J. C. M.
|
|
|
100 |
12 |
p. 2921-2932
|
artikel
|
| 31 |
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia
|
Wellbrock, Jasmin
|
|
|
100 |
12 |
p. 2933-2941
|
artikel
|
| 32 |
The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia
|
Yanada, Masamitsu
|
|
|
100 |
12 |
p. 3017-3027
|
artikel
|
| 33 |
The optimal timing of radiotherapy in the combination treatment of limited-stage extranodal natural killer/T-cell lymphoma, nasal type: an updated meta-analysis
|
Cui, Yue
|
|
|
100 |
12 |
p. 2889-2900
|
artikel
|
Tijdschrift beschrijving